Mark Allegretta

Dr. Allegretta has over 20 years of experience in biotechnology and academic research and development. He received his PhD from the University of Vermont in 1990, and was a post-doctoral fellow at Stanford University School of Medicine. Dr. Allegretta is a co-founder of EndoGen and was most recently associated with Connetics Corporation and InterMune Pharmaceuticals. He is currently Associate Vice President, Research for the National Multiple Sclerosis Society.